Department of Otolaryngology-Head and Neck Surgery, NYU Langone, New York, New York.
Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa.
Otol Neurotol. 2024 Oct 1;45(9):1016-1022. doi: 10.1097/MAO.0000000000004314.
To better understand cochlear implant (CI) performance after reimplantation with a different device manufacturer.
Multisite retrospective review.
Tertiary referral centers.
Patients older than 4 years who received a CI and subsequently underwent CI reimplantation with a different manufacturer over a 20-year period.
Reimplantation.
The primary outcome was difference in the best CNC score obtained with the primary CI, compared with the most recent CNC score obtained after reimplantation.
Twenty-nine patients met the criteria at three centers. The best average CNC score achieved by adult patients after primary cochlear implantation was 46.2% (n = 16), measured an average of 14 months (range: 3-36 mo) postoperatively. When looking at the most recent CNC score of adult patients before undergoing reimplantation, the average CNC score dropped to 19.2% (n = 17). After reimplantation, the average 3- to 6-month CNC score was 48.3% (n = 12), with most recent average CNC score being 44.4% (n = 17) measured an average of 19 months (range: 3-46 mo) postoperatively. There was no statistically significant difference (p = 0.321; t11 = 0.48) identified in performance between the best CNC score achieved by adult patients after primary cochlear implantation, and the most recent score achieved after reimplantation (n = 12). Analysis of prerevision and postrevision speech performance was not possible in pediatric patients (<18 yr old) because of differences in tests administered.
Patients undergoing reimplantation with a different manufacturer achieved CNC score performance comparable to their best performance with their original device.
更好地了解不同设备制造商的人工耳蜗(CI)再植入后的性能。
多地点回顾性研究。
三级转诊中心。
4 岁以上接受 CI 植入并在 20 年内接受不同制造商的 CI 再植入的患者。
再植入。
主要结果是使用原设备获得的最佳 CNC 评分与再植入后最近获得的 CNC 评分之间的差异。
在三个中心有 29 名患者符合标准。成人患者在初次耳蜗植入后获得的最佳平均 CNC 评分是 46.2%(n=16),平均术后 14 个月(范围:3-36 个月)测量。当查看成人患者在接受再植入前的最近 CNC 评分时,平均 CNC 评分降至 19.2%(n=17)。再植入后,3-6 个月的平均 CNC 评分为 48.3%(n=12),最近的平均 CNC 评分为 44.4%(n=17),平均术后 19 个月(范围:3-46 个月)测量。在初次耳蜗植入后成年患者获得的最佳 CNC 评分与再植入后最近获得的评分(n=12)之间,未发现统计学上的显著差异(p=0.321;t11=0.48)。由于所进行的测试不同,无法对儿科患者(<18 岁)进行术前和术后言语表现的分析。
接受不同制造商再植入的患者获得的 CNC 评分表现与他们使用原始设备获得的最佳表现相当。